A Randomized, Double-Blinded, Phase II Study of Maintenance Pembrolizumab versus Placebo after First-line Chemotherapy in Patients with Metastatic Urothelial Cancer - Regional Cancer Care Associates LLC

Clinical Trials

A Randomized, Double-Blinded, Phase II Study of Maintenance Pembrolizumab versus Placebo after First-line Chemotherapy in Patients with Metastatic Urothelial Cancer

Type of Cancer
Genito-Urinary
Locations
Hackensack
Sponsor
Hoosier
Protocol Number
GU14-182
Cancer Diagnosis
To Learn More Call
201-510-0910